Search Results - "Vishwanath, Divakar"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1
  2. 2
  3. 3

    Design and Activity of Novel Oxadiazole Based Compounds That Target Poly(ADP-ribose) Polymerase by Vishwanath, Divakar, Girimanchanaika, Swamy S, Dukanya, Dukanya, Rangappa, Shobith, Yang, Ji-Rui, Pandey, Vijay, Lobie, Peter E, Basappa, Basappa

    Published in Molecules (Basel, Switzerland) (21-01-2022)
    “…Novel PARP inhibitors with selective mode-of-action have been approved for clinical use. Herein, oxadiazole based ligands that are predicted to target PARP-1…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Electrochemical Synthesis of Versatile Pyrimidine and Oxadiazoles Tethered Triazoles as Inhibitors of VEGFR-2 in Human Breast Cancer Cells by Akshay Ravish, Tejaswini P. Siddappa, Zhang Xi, Divakar Vishwanath, Arunkumar Mohan, Shreeja Basappa, Niranjan Pattehalli Krishnamurthy, Peter E. Lobie, Vijay Pandey, Basappa Basappa

    Published in Catalysts (01-10-2023)
    “…Metastasis, the dissemination of tumor cells, stands as the second most prominent contributor to mortality arising from breast cancer. To counteract this…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9

    New Heparanase-Inhibiting Triazolo-Thiadiazoles Attenuate Primary Tumor Growth and Metastasis by Barash, Uri, Rangappa, Shobith, Mohan, Chakrabhavi Dhananjaya, Vishwanath, Divakar, Boyango, Ilanit, Basappa, Basappa, Vlodavsky, Israel, Rangappa, Kanchugarakoppal S.

    Published in Cancers (13-06-2021)
    “…Compelling evidence ties heparanase, an endoglycosidase that cleaves heparan sulfate side (HS) chains of proteoglycans, with all steps of tumor development,…”
    Get full text
    Journal Article
  10. 10